CDW (CDW) is projected to see its revenue rise 3.7% per year, lagging behind the broader US market’s 10.5% forecast. Annual EPS growth is also slower, expected at 9.4% compared to the US market’s 16%.
‘I learned a hard lesson’: My ex-husband gambled away our $900,000 life savings. Do I use my 401 (k) to buy a home? Actor Jeff Bridges has a message for lawmakers as millions are set to lose food ...
Hosted on MSN
These schools are using DEI as an important tool to 'screen people out,' says professor
University of Washington professor Cliff Mass discusses a job position at the school that requires applicants to provide a 'one-page diversity statement' on 'The Ingraham Angle.' Republican takes lead ...
For more than half a century, scientists have debated whether Paranthropus boisei, an extinct human relative known for its extremely powerful jaws and massive teeth, was capable of making and using ...
Our Protein Instability Index Calculator is a powerful, web-based tool for evaluating the stability of your protein sequences. By simply inputting a sequence, you can instantly compute its Instability ...
Lloyds Banking Group will monitor its Workday HR software to help it identify the lowest-performing staff, who could be cut as part of its latest cull, according to the union. A Financial Times report ...
"It's not the heat. It's the humidity." Sound familiar? I think we're all guilty of saying that at some point between June and September. The heat index isn't just some made-up number to inflate ...
Artificial intelligence (AI) is soaring in popularity, and cybercriminals have taken note. As more people search for the latest and greatest AI tools to boost their productivity, some criminals have ...
Developer tooling startup PostHog Inc. has raised $70 million in funding, Crunchbase reported today. Payment processing provider Stripe Inc. led the Series D investment. It was joined by Alphabet Inc.
Exploratory biomarker analysis of trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in HER2-low/ultralow, hormone receptor–positive (HR+) metastatic breast cancer (mBC) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results